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Abstract
Alterations in histone lysine methylation and epigenetic regulators of gene expression could
play a role in the neurobiology and treatment of patients diagnosed with mood spectrum dis-
order, including depression and anxiety. Mutations and altered expression of various lysine
methyltransferases (KMTs) and demethylases (KDMs) have been linked to changes in mo-
tivational and emotional behaviors in preclinical model systems. However, it is not known
whether regulators operating downstream of histone lysine methylation could affect mood-
related behavior.Malignant Brain Tumor (MBT) domain ‘chromatin reader’ proteins bind to
methylated histone lysine residues and associate with chromatin remodeling complexes to
facilitate or repress gene expression. MBT proteins, including the founding member,
L3mbtl1, maintain high levels of expression in neurons of the mature brain. Here, we ex-
posed L3mbtl1 null mutant mice to a wide range of tests exploring cognition and mood-
relevant behaviors at baseline and in the context of social isolation, as a stressor to elicit de-
pression-related behavior in susceptible mice. L3mbtl1 loss-of-function was associated
with significant decreases in depression and and anxiety in some of the behavioral para-
digms. This was not associated with a more generalized neurological dysfunction because
cognition and memory remained unaltered in comparison to controls. These findings war-
rant further investigations on the role of MBT chromatin reader proteins in the context of
emotional and affective behaviors.
Introduction
Mood spectrum disorders, including depression and various anxiety disorders [1], cause signif-
icant morbidity and mortality with at least 40% of subjects only partially responding to cur-
rently available pharmacological treatments that primarily target monoamine metabolism and
reuptake [2]. Among the novel therapeutic avenues currently pursued in preclinical studies are
epigenetic mechanisms, affecting chromatin structure and function as well as gene expression
PLOSONE | DOI:10.1371/journal.pone.0121252 April 7, 2015 1 / 12
OPEN ACCESS
Citation: Shen EY, Jiang Y, Mao W, Futai K, Hock H,
Akbarian S (2015) Cognition and Mood-Related
Behaviors in L3mbtl1 Null Mutant Mice. PLoS ONE
10(4): e0121252. doi:10.1371/journal.pone.0121252
Academic Editor: Kazuya Iwamoto, University of
Tokyo, JAPAN
Received: November 12, 2014
Accepted: January 31, 2015
Published: April 7, 2015
Copyright: © 2015 Shen et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: This work was supported by National
Institutes of Health grants R01MH086509 and
P50MH096890. The funders had no role in study
design, data collection and analysis, decision to
publish, or preparation of the manuscript.
Competing Interests: The authors have declared
that no competing interests exist.
in response to diverse stimuli [3,4]. Various regulators of post-translational histone modifica-
tions, including enzymes targeting histone lysine residues for deacetylation, methylation, and
demethylation, recently emerged as promising starting points for novel epigenetic drug targets
in the treatment of depression and anxiety based on work in animal models and postmortem
brain of subjects diagnosed with major mood disorders and other psychiatric disease [5–13].
Much less is known the molecular machinery operating downstream of the histone modifica-
tions implicated in neuronal plasticity and behavior, such as ‘chromatin-readers’ [14].
Malignant Brain Tumor (MBT) domain chromatin reader proteins bind to methylated his-
tone lysine residues and associate with chromatin remodeling complexes. These include typical
and atypical Polycomb repressor complexes that control expression of genes with essential
roles in cell cycle regulation and early development [15,16]. Several MBT proteins, including
the founding member, L3mbtl1, maintain very high levels of expression in mature brain with
broad, near-ubiquitous expression in fore-, mid- and hindbrain neurons [17]. This suggests
that MBT proteins may serve yet unknown functions in terminally differentiated brain cells.
Proper cell-type specific regulation of histone methylation landscapes is essential for normal
brain function [18,19], and rare mono- or oligogenic forms of cognitive disease have been
linked to mutations in histone lysine methyltransferase (KMT) and demethylase (KDM) genes.
These broadly affect the epigenetic landscapes at sites of open or repressive chromatin [5,20–
22]. Motivational and emotional behaviors have also been linked to histone lysine methylation.
For example, Kmt1a(Suv39h1)-, Kmt1c(G9a)- and Kmt1e(Setdb1)-mediated repressive H3K9
methylation regulate amphetamine reward [23,24] and antidepressant-like behaviors in mice
[25]. Furthermore, monoamine oxidase inhibitors exert powerful effects on mood and cogni-
tion primarily by elevating brain monoamine levels, but, intriguingly, some members of this
class of drugs also interfere with lysine methylation pathways by blocking Kdm1a/Lsd1 amine
oxidase domain containing KDMs [26,27]. Therefore, exploration of regulators and readers of
histone lysine methylation marks, such as the MBT family of genes, bears potential promise to
discover novel treatment avenues for mood spectrum disorders, including anxiety and depres-
sion. However, there is very little information on neurological phenotypes after loss of specific
MBT genes. Thus it remains unclear whether the MBT lysine methylation reader proteins are
essential for mature brain function. Here, we provide a detailed account for a comprehensive
behavioral assessment of adult L3mbtl1 null mutant mice exposed to a wide range of behavioral
tests at baseline and after single housing as a social isolation stressor eliciting depression-relat-
ed behavior in susceptible mice [28].
Methods
All animal work of this study has been approved by the Institutional Animal Care and Use
Committee of the Icahn School of Medicine at Mount Sinai. Generation of L3mbtl1-/- null mu-
tant line has been described previously [29]. Mice are held under specific pathogen-free condi-
tions with food and water being supplied ad libitum in an animal facility with a reversed 12 h
light/dark cycle (light off at 7:00 am) under constant conditions (21 ± 1°C; 60% humidity).
For the present study, male and female null mutant and wildtype mice, all from the same
colony in a predominant C57Bl6/J background, back-crossed for at least 5 generations, and
3–6 months of age, were used. Furthermore, all mice used for the actual experiments were de-
rived from heterozygous (L3mbtl1+/-) breeder pairs. For all test conditions, the male:female
ratio was approximately 1:1, and each mutant animal was analyzed in parallel to one or two
sex-matched wildtype control of the same age ± 2 weeks. All animals had access to food and
water ad libidum. All animals (including those exposed to social isolation were monitored at
least 2–3 times each week to assess well-being and to monitor for any signs of distress.
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Anxiety assays
Open field locomotion test. This test was monitored in test chambers using a photocell-
beam-based computer detecting system (OmniTech Electronics. Inc). The apparatus consisted
of an arena (40 x 40 cm) surrounded by 40 cm high walls made from clear plastic. Animals
were introduced into the corner of the test chamber and allowed free exploration for 20 min in-
dividually under standard room lighting conditions. The beam breaks were recorded every 5
min to evaluate the spontaneous locomotor activity. Total distance (indicative of locomotor ac-
tivity) and the duration of time the animals spent in the central and peripheral areas were
also calculated.
The light/dark box test. This test was performed in the open field arena with a black
box insert (20 cm L x 20 cmW x 40 cm H), dividing the arena into dark and light components
connected by a small hole. Animals were introduced into the dark chamber and allowed free
exploration for 10 min. The duration of time spent in the dark and light chambers
were calculated.
Elevated Plus Maze test. The elevated plus maze (Med Associates Inc) contained a center
square (6cm x 6cm), two open arms, and two closed arms (measuring 35cm x 6cm each). The
closed arms were enclosed by black polypropylene walls measuring 20 cm in hight. Mice were
placed in the center square facing one of the closed arms. Time spent in each arm was recorded
and scored by the EthoVision video tracking system. A decrease in time spent in the open arms
reflects a state of increased anxiety.
Behavioral despair/depression assays
Tail suspension test. Animals were suspended with duct tape by the tail. Animals showing
tail climbing behaviors were removed from the statistical analysis. The whole test was video-
taped for 5 minutes. Latency to first freezing and the time spent immobile was evaluated by
EthoVision software (Noldus, Wageningen, The Netherlands).
Forced swim test. Animals were placed into a 4 L Pyrex beaker (13 cm diameter, 24 cm
height) filled with 17cm of 22°C water. The whole test was videotaped for 5 minutes. Latency
to first freezing and time spent immobile was evaluated by EthoVision software.
Cognition and working memory assays
Contextual fear conditioning test. Contextual fear conditioning was conducted in a fear
conditioning chamber fromMed Associates Inc. Mice were placed in the chamber for a 7 min
training session during which time 3 shocks were delivered. The percentage of time freezing be-
fore the first shock (baseline) and after each shock was measured. After 24 hours, mice were re-
turned to the same chamber for a 3-min retrieval testing and percentage of time freezing
was measured.
Radial arm maze test. The radial arm maze test was conducted to measure working mem-
ory. The apparatus consisted of 8 arms (5 x 50 cm; 30 cm high walls), which were assembled in
a radial manner around a circular starting platform. Mice were tested for 4 consecutive days in
the apparatus. On each day mice were placed onto the starting platform and were free to enter
the arms. The test was continued until all eight arms had been visited at least once. A mistake
was defined as a repeated entry to an already visited arm before each of the eight arms was vis-
ited. Total mistakes during each session were measured. Because this protocol measures spon-
taneous alternations, food deprivation in conjunction with baited arms was not used.
Dopamine-mediated locomotion test. For this test, mice were placed into an open-field
chamber (OmniTech Electronics. Inc) with their baseline activity recorded for 30 min, then in-
jected with 0.9% saline and locomotor activity recorded for 30 additional min. Finally, mice were
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injected with the D1 receptor agonist SKF81297 at doses of 0.5 and 1 mg/kg body weight and re-
corded for a final 90 min.
Social Isolation Stress Test
Single housing test. All animals were consistently group-housed during the entire pre-
and post-weaning period, until the beginning of postnatal week four when a subset were
switched to single-housed. After a 3-month single-housing period, behavioral testing on anxi-
ety, depression, working memory and locomotion were conducted in single-housed mice, in
parallel to group-housed mice.
Statistical analyses
Two-tailed unpaired t-test was applied to test for significance of differences between
L3mbtl1-/- and wildtype controls for body weight, behavioral despair (tail suspension and
forced swim) and anxiety (elevated plus maze, light/dark box) test. For comparison of group-
vs. single-housed animals (open field, behavioral despair, radial arm maze), two-way ANOVA
followed by post-hoc t-test was applied. For monitoring locomotor activity after acute treat-
ment with D1 agonist (SKF81297), repeated measures ANOVA was applied, followed by post-
hoc t-test when indicated.
Results
We reported previously that L3mbtl1-/- null mutant mice exhibit normal life expectancy, a
grossly normal brain morphology and cytoarchitecture, and scorings in a locomotor coordina-
tion test that were indistinguishable from controls[29]. Notably, however, both male and fe-
male L3mbtl1-/- show a subtle but significant reduction in body weight at 3–6 months of age
(approximately 10%) compared to gender- and age-matched controls, while overall locomotor
activity was indistinguishable between mutants and controls (Fig 1A). This is likely important
because a wide range of genetically engineered mice with altered baseline body weight fre-
quently show robust changes in motivational and affective behaviors. Such abnormalities were,
for example, observed in mouse lines carrying loss-of-function mutations for specific chroma-
tin regulators like the Rett syndrome geneMethyl-CpG-binding protein 2 (Mecp2)[30–32], and
the transcription factor Circadian locomotor cycles output kaput (Clock)[33,34]. Therefore, we
asked whether depression and anxiety-related behaviors are altered in L3mbtl1-/-mice that
were kept under normal ‘non-stressed’ group-housing conditions (2–3 sex-matched littermates
as cage mates after weaning).
We first applied two widely used depression-relevant tests, the forced swim and tail suspen-
sion tests, which are considered behavioral despair paradigms[35], as a measure for depression
[36] and, importantly, as measure for the effectiveness of antidepressant drugs [37]. Interest-
ingly, L3mblt1-/-mice showed a significant, approximately 30% decrease in immobility in the
tail suspension test (Fig 1B, panel a). Likewise, mutant mice showed a subtle, approximately
15% decrease in immobility in the forced swim test, in comparison to L3mbtl1+/+ controls (Fig
1B, panel b). Both of these tests suggested that L3mbtl1 loss reduced behavioral patterns associ-
ated with depression.
Because depression and anxiety spectrum disorders show considerable overlap in terms of
diathesis and underlying neurobiology [1,38,39], we next explored the performance of
L3mbtl1-/-mice in several anxiety-relevant paradigms. We applied the elevated plus maze,
which is based on the animals aversion of open spaces, resulting in avoidance of open areas
and confining movements to enclosed spaces [40]. However, both L3mbtl1 null mutant and
Methyl-Reader L3mbtl1 in Anxiety and Depression
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Fig 1. Behavioral summary of L3mbtl1 null mutant and control mice at baseline. (A) General activity, (a)
body weight and (b) locomotion. (B) Depression, (a) forced swim and (b) tail suspension (N = 25-28/genotype
and test). (C) Anxiety, (a) elevated plus maze, (b) light-dark box, (c) open-field test (N = 17–21 genotype/test).
(D) cognition, assessed by contextual fear conditioning (N = 12 L3mbtl1-/- and N = 17 L3mbtl1+/+). Animals
used for general activity and depression assays were from a different batch than the animals used for anxiety
assays. A third batch of animals was used for the fear conditioning assays. All animals are kept under
baseline conditions (group housing). All data are shown as mean ± S.E.M., * P<0.05; independent-samples
t test and, for fear conditioning assay, repeated measures ANOVA.
doi:10.1371/journal.pone.0121252.g001
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control animals showed a similar strong preference for the closed as opposed to the open arms
in the elevated plus maze (Fig 1C, panel a).
Next, we tested in the animals in the light-dark box test [41]. The test’s basic measure is the
animal’s preference for dark, enclosed places over bright, exposed places. The time spent in the
light box, and the related exploratory behaviors, inform about the level of anxiety. The
L3mbtl1-/-mice showed a significant decrease in latency to enter the bright chamber in the
light-dark box test [41], indicating decreased anxiety (Fig 1C, panel b). We then applied a third
anxiety paradigm, the open field test [42]. This test measures emotionality and anxiety in ro-
dents, including the time spent in the (anxiogenic) open center (as opposed to the for rodents
less anxiogenic space along the apparatus’ walls), and the general activity in the first few min-
utes after being place into the apparatus [43]. Of note, the L3mbtl1 -/-mice spent more time in
the center by a 15% difference across the 20 min test period (Fig 1C, panel c). The latter result
did not reach statistical significance but is consistent with the notion that anxiety was reduced.
Taken together, these findings suggest that L3mbtl1 disruption is followed by subtle anxiolytic
and antidepressant-like effects that become manifest in some but not all depression- and anxi-
ety-related paradigms. To further examine whether these phenotypes in L3mbtl1-/- null mice
are representative of broader changes in cognition and behavior, we exposed animals to a con-
textual fear paradigm exploring retrieval-dependent freezing behavior 24 hours after exposure
to electrical foot shocks in the same test chamber. This test essentially explores cognitive behav-
ioral plasticity resulting from coupling a neutral stimulus with an aversive stimulus, and is
heavily dependent on neural circuitry of the amygdala, while the role of the hippocampus is
less prominent for this type of learning[44]. However, retrieval was indistinguishable between
mutant and controls (Fig 1D), suggesting normal long-term memory function in L3mbtl1 null
mice. Nevertheless, mutant mice showed a consistent, 25–40% decline in freezing time across
all three training days, which was significant (P<0.05, repeated measures ANOVA) (Fig 1D).
Given that L3mbtl1mutant mice exhibit subtle alterations in anxiety-related behavior at
baseline, we then asked whether cognitive and emotional functions show changes in the con-
text of a stressor such as social isolation by housing mice individually. Such stressors elicit de-
pression-related behaviors in susceptible mice [28]. To this end, another batch of mutant and
controls (different from the animals used for the studies shown in Fig 1A–1D) were single- or
group-housed after weaning, then at 3–4 months of age subjected to open field (anxiety) and
forced swim (behavioral despair) and the eight-arm radial arm maze for working memory. In
rodents, increased open field locomotion after a period of social isolation is thought to reflect
increased levels of anxiety[45]. As expected, social isolation induced increased open field loco-
motion in L3mbtl1+/+ animals, but this effect was completely lacking in socially isolated
L3mbtl1-/-, or in group-housed mice (Fig 2A). The ~ 25–30% increase in locomotion after so-
cial isolation in L3mbtl1+/+, in comparison to null mutant mice, was significant (Fig 2A) and
may indicate that loss of L3mbtl1 renders mice less susceptible to increased anxiety after certain
types of stress. However, single housing induced both in L3mbtl1 null and wildtype mice an ~
25% increase in despair-induced immobility in the forced swim paradigm compared to group-
housed animals (Fig 2B). Furthermore, housing conditions did not affect performance in the
open field test (Fig 2C). Thus, L3mbtl1-/- showed a specific resilience to social isolation in the
open field, but not in other anxiety- and depression-related tests.
Next, we measured spatial working memory as measured by repeat entries (‘errors’) in the
8-arm radial maze in group- and single-housed L3mbtl1+/+ and L3mblt1-/-mice. Importantly,
working memory, defined as a limited capacity storage system involved in information process-
ing over a short time period [46], is associated with a variety of emotional aspects and sensitive
to stress and depression [47]. Therefore, we hypothesized that L3mbtl1-/-mice may perform
differently from controls in such type of cognitive task. In the 8-arm radial maze paradigm,
Methyl-Reader L3mbtl1 in Anxiety and Depression
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applied once daily for 4 days, single-housed L3mbtl1-/- tended to outperform single-housed
controls but these differences did not reach the level of significance and no consistent genotype
effect was observed overall (Fig 2D).
Dopaminergic activity, including dopamine D1-receptor mediated signaling, is also sensi-
tive to stressful exposure and potentially altered in some of the depression-relevant paradigms
[48]. Therefore, in our final set of experiments, using naive animals that had not been included
in any of our behavioral assays described above, we explored the effects of a dopaminergic drug
on group- versus single housing on locomotor activity in L3mbtl1-/- and L3mbtl1+/+mice,
using the open field apparatus. We treated mice (after 30 min with saline and, after another pe-
riod of 30 min) with SKF81297, a dopamine D1 receptor agonist and mild stimulant drug [49],
at doses of first 0.5 mg/kg and subsequently 1 mg/kg. Animals had one week of rest before re-
ceiving the second dose. In this paradigm, L3mbtl1-/-mice showed subtle decreases in
Fig 2. Behavioral summary in group housed versus single housed (3 months of social isolation)
L3mbtl1 null mutant and wildtype mice. The figure summarizes the following tests in group and single
housed mice, as indicated (A) General activity/locomotion. (B) Depression/ forced swim. (C) Anxiety/open
field test. (N = 8 group housed L3mbtl1-/-, N = 10 group housed L3mbtl1+/+, N = 10 single housed
L3mbtl1-/-, N = 10 single housed L3mbtl1+/+). (D) Cognition/radial arm maze (N = 8 group housed
L3mbtl1-/-, N = 11 group housed L3mbtl1+/+, N = 11 single housed L3mbtl1-/-, N = 10 single housed
L3mbtl1+/+). Behavioral assays were conducted in the order from the least to the most stressful, and thus (i)
activity/locomotion, followed by (ii) radial arm maze, followed by (iii) anxiety/open field, and (iv) depression /
forced swim as the final test. All data shown as mean ± S.E.M., * P<0.05; independent-samples t-test after
two-way ANOVA: for (A) locomotion: F(1,34) = 3.807, P = 0.05, Bonferroni post test P<0.05 for single housed
L3mbtl1-/- vs. L3mbtl1+/ +); for (B) forced swim: F(1,34) = 10.93, P = 0.022, Bonferroni post test P<0.01 for
single vs. group housed; for (C), (D) no significance. All data shown in Fig 2 are from batches of mice different
from those shown in Fig 1.
doi:10.1371/journal.pone.0121252.g002
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locomotor activity, while both mutant and wildtype animals showed increased locomotion
after administration of the dopaminergic drug, as expected (Fig 3A and 3B). However, signifi-
cant differences were limited to group-housed animals due to increased locomotion in wildtype
animals at multiple time points before and after administration of the higher (1mg/kg) dose of
SKF81297 (Fig 3B). We conclude that L3mblt1-/-mutant mice indeed show decreased locomo-
tor activity for at least some of the time periods tested in the open field paradigm, but this is
not associated with a generalized hyper- or hypo-responsiveness to dopamine D1 receptor ago-
nists. These data would suggest that alterations in dopamine D1 signaling are unlikely to be a
major factor in the subtle changes in mood and anxiety related behaviors in the L3mbtl1 null
mutant mice of the present study.
Discussion
MBT-domain proteins, including L3MBTL1, bind to methylated lysine residues and regulate
chromatin structure and function by mediating nucleosomal compaction and affecting the ac-
tivity of chromatin remodeling complexes, such as Polycomb[50–52]. L3mbtl1 is highly ex-
pressed in neurons of the adult mouse brain. As fine-tuning and regulation of histone lysine
methylation marks is pivotal for neuronal plasticity and complex behaviors, we hypothesized
that L3mbtl1 null mutant mice will show alterations in a broad range of emotional and cogni-
tive behaviors, in comparison to L3mbtl1+/+ control mice from the same colony. Of note,
L3mbtl1-/-mice have normal life expectancy, and show a subtle, but significant, reduction in
body weight compared to controls. However, in line with a previous study exploring the inter-
relation between body weight and isolation-induced stress and emotional functions in mice
[53], the subtle, ~ 10% reduction in body weight in the mutant mice of our study is unlikely to
account for the mild behavioral phenotypes that define these animals. Furthermore, the associ-
ation between body weight and cognitive and emotional functions is complex, with the same
behavioral phenotype, for example increased anxiety, reported both in mice with decreased
[54] or increased [55] body weight. The L3mbtl1-/- cohort of the present study exhibited
Fig 3. Locomotor effects of D1 agonist SKF81297. The figure summarizes SKF81297-induced locomotion
at (A) 0.5mg/kg and (B) 1mg/kg i.p., administered 60 min after placing mice into the open field apparatus and
30 min after a saline control injection. Assays were conducted in group and single housed animals, as
indicated (N = 5 group housed L3mbtl1-/-, N = 9 group housed L3mbtl1+/+) and single-housed animals N = 4
single housed L3mbtl1-/-, N = 5 single housed L3mbtl1+/+). All data are shown as mean ± S.E.M. (B)
repeated measures ANOVA F(1,14) = 3.203 with time point T 60 min Bonferroni post test P<0.05, other time
timepoints *, P<0.05 by independent sample t-test. All data in Fig 3 are from experimentally naive mice.
doi:10.1371/journal.pone.0121252.g003
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significantly decreased anxiety in the light-dark box paradigm, and after social isolation as
stressor, in the open field test. However, this was not associated with generalized changes in
anxiety and depression-related behaviors, because despair-related immobility scores in the
forced swim and tail suspension tests, and performance in the elevated plus maze as an addi-
tional measure for anxiety, were not consistently different from controls. We note that immo-
bility times in behavioral despair paradigm were reduced in some cohorts of L3mbtl1-/-
mutant mice (Fig 1B), but such an effect was not observed in another set of animals in which
genotype was examined together with housing conditions (group- versus single housed) (Fig
2B). Similarly, shock-induced retention was maintained after L3mbtl1 deletion in the fear con-
ditioning paradigm, despite the significant decrease in freezing times during the training ses-
sions in null mutant mice (Fig 1D). Moreover, spatial working memory was not significantly
different between genotypes both at baseline and after social isolation stress (Fig 2D). Locomo-
tor activity in a novel environment (Figs 1A and 2A) and in the context of acute changes in do-
paminergic signaling (Fig 3B) showed a subtle decrease in the mutants, but this effect was
variable and not consistently observed across stressed and non-stressed conditions (Fig 3B).
Taken together, our findings demonstrate that L3mbtl1 loss causes subtle changes in behav-
ior in some but not all of the tests applied. Importantly, lower anxiety scores were evident in at
least two independent paradigms (light-dark box and open field test after social isolation).
These findings are interesting given that other regulators of histone lysine methylation had
been previously implicated to influence depression- and anxiety-related phenotypes. For exam-
ple, mice with transgene-mediated overexpression of KMT1E/SETDB1/ESET histone H3-ly-
sine 9 methyltransferase show robust antidepressant-like phenotypes in behavioral paradigms
for despair, learned helplessness and anhedonia (defined as the inability to experience plea-
sure)[25]. Conversely, mice with a null mutation of Kap1, encoding the KMT1E-binding part-
ner KRAB-associated protein 1, display elevated levels of anxiety together with impairments in
learning and memory [56]. Notably, in mice exposed to social defeat, which is a strong stressor
linked to the emergence of depression-related phenotypes, the H3K9-specific demethylase
Kdm3a is subject to repressive chromatin remodeling in the ventral striatum, a key structure in
the neuronal circuitry controlling emotional and affective behaviors [57]. In some studies,
global changes in hippocampal histone methylation have been linked to depression-related
phenotypes [58,59]. There is also evidence that non-selective monoamine oxidase inhibitors
acting as antidepressants could potentially inhibit LSD1 type histone demethylases (which con-
tain an amine oxidase domain) even at within the therapeutic range of these drugs [60]. There-
fore, the present findings implicating L3mbtl1 in the control of mood and behavior warrant
further investigation to explore the therapeutic potential of this histone methyl-reader protein
in psychiatric disorders. For example, it will be interesting to explore chromatin sites and target
genes regulated by L3mbtl1 and other MBT proteins in preclinical models for anxiety
and depression.
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